Effects of paraxanthine on brain functio
Not Applicable
Completed
- Conditions
- Improving executive functioning in healthy individualsNot Applicable
- Registration Number
- ISRCTN66975000
- Lead Sponsor
- Ingenious Ingredients L.P.
- Brief Summary
2021 Results article in https://doi.org/10.3390/nu13113980 (added 19/11/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
Apparently healthy males and females between the ages of 18 to 59 were recruited to participate in the study.
All subjects were healthy and free from known:
1. Cognitive deficit conditions
2. Wheat flour allergies
3. Sleep disorders
4. Cardiovascular, metabolic, or pulmonary diseases
5. History of hypertension, migraine headaches, cardiac arrhythmias, or anxiety
6. Gastrointestinal reflux disease or ulcers
Exclusion Criteria
Subjects who were taking prescription medications in the month prior to the initiation of the study and/or were told by a physician to abstain or restrict caffeine and/or stimulant intake were excluded from the present study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> The Psychology Experiment Building Language (PEBL) software program (Version 2.1, http://pebl.sourceforge.net) was used to administer four cognitive function tests that assessed a range of cognitive and executive function aspects:<br> 1. Berg-Wisconsin Card Sorting Task test (BCST) at baseline, 1, 2, 3, 4, 5 and 6 hours after ingestion<br> 2. The Go/No-Go test (GNG) at baseline, 1, 2, 3, 4, 5 and 6 hours after ingestion<br> 3. Sternberg Task Test (STT) at baseline, 1, 2, 3, 4, 5 and 6 hours after ingestion<br> 4. Psychomotor Vigilance Task Test (PVTT) at baseline, 1, 2, 3, 4, 5 and 6 hours after ingestion<br>
- Secondary Outcome Measures
Name Time Method There are no secondary outcome measures